122 related articles for article (PubMed ID: 32203934)
1. Regulation of docetaxel chemosensitivity by NR2F6 in breast cancer.
Zhang J; Meng H; Zhang M; Zhang C; Huang M; Yan C; Wang Z; Hou L; Yang L; Ling R
Endocr Relat Cancer; 2020 May; 27(5):309-323. PubMed ID: 32203934
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of docetaxel sensitivity by miR-638 via regulation of STARD10 pathway in human breast cancer cells.
Zhao G; Li Y; Wang T
Biochem Biophys Res Commun; 2017 May; 487(2):255-261. PubMed ID: 28412359
[TBL] [Abstract][Full Text] [Related]
3. Docetaxel-loaded PAMAM-based poly (γ-benzyl-l-glutamate)-b-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles in human breast cancer and human cervical cancer therapy.
Wang Y; Zuo A; Huang X; Ying Y; Shu X; Chen X; Yang Y; Ma J; Lin G; Wang X; Mei L; Liu G; Zhao Y
J Microencapsul; 2019 Sep; 36(6):552-565. PubMed ID: 31403342
[TBL] [Abstract][Full Text] [Related]
4. CHCHD2 decreases docetaxel sensitivity in breast cancer via activating MMP2.
Ma L; Zheng LH; Zhang DG; Fan ZM
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6426-6433. PubMed ID: 32572940
[TBL] [Abstract][Full Text] [Related]
5. Identification of FOXE3 transcription factor as a potent oncogenic factor in triple-negative breast cancer.
Wang H; Yang T; Yuan Y; Sun X
Biochem Biophys Res Commun; 2020 Feb; 523(1):78-85. PubMed ID: 31831170
[TBL] [Abstract][Full Text] [Related]
6. Development of novel biotinylated chitosan-decorated docetaxel-loaded nanocochleates for breast cancer targeting.
Poudel I; Ahiwale R; Pawar A; Mahadik K; Bothiraja C
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):229-240. PubMed ID: 29575931
[TBL] [Abstract][Full Text] [Related]
7. Ccl3 enhances docetaxel chemosensitivity in breast cancer by triggering proinflammatory macrophage polarization.
Sheng D; Ma W; Zhang R; Zhou L; Deng Q; Tu J; Chen W; Zhang F; Gao N; Dong M; Wang D; Li F; Liu Y; He X; Duan S; Zhang L; Liu T; Liu S
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35613826
[TBL] [Abstract][Full Text] [Related]
8. The Altered Transcriptome and DNA Methylation Profiles of Docetaxel Resistance in Breast Cancer PDX Models.
Gómez-Miragaya J; Morán S; Calleja-Cervantes ME; Collado-Sole A; Paré L; Gómez A; Serra V; Dobrolecki LE; Lewis MT; Diaz-Lagares A; Eroles P; Prat A; Esteller M; González-Suárez E
Mol Cancer Res; 2019 Oct; 17(10):2063-2076. PubMed ID: 31320385
[TBL] [Abstract][Full Text] [Related]
9. Exploring the Promising Potential of High Permeation Vesicle-Mediated Localized Transdermal Delivery of Docetaxel in Breast Cancer To Overcome the Limitations of Systemic Chemotherapy.
Bathara M; Date T; Chaudhari D; Ghadi R; Kuche K; Jain S
Mol Pharm; 2020 Jul; 17(7):2473-2486. PubMed ID: 32496783
[TBL] [Abstract][Full Text] [Related]
10. Incorporation of docetaxel and thymoquinone in borage nanoemulsion potentiates their antineoplastic activity in breast cancer cells.
Alkhatib MH; Bawadud RS; Gashlan HM
Sci Rep; 2020 Oct; 10(1):18124. PubMed ID: 33093596
[TBL] [Abstract][Full Text] [Related]
11. TGF-β causes Docetaxel resistance in Prostate Cancer via the induction of Bcl-2 by acetylated KLF5 and Protein Stabilization.
Li Y; Zhang B; Xiang L; Xia S; Kucuk O; Deng X; Boise LH; Dong JT
Theranostics; 2020; 10(17):7656-7670. PubMed ID: 32685011
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of raloxifene-targeted poly(styrene maleic acid)-poly (amide-ether-ester-imide) co-polymeric nanomicelles loaded with docetaxel in breast cancer-bearing mice.
Enteshari S; Varshosaz J; Minayian M; Hassanzadeh F
Invest New Drugs; 2018 Apr; 36(2):206-216. PubMed ID: 29177974
[TBL] [Abstract][Full Text] [Related]
13. Docetaxel-loaded solid lipid nanoparticles prevent tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells.
da Rocha MCO; da Silva PB; Radicchi MA; Andrade BYG; de Oliveira JV; Venus T; Merker C; Estrela-Lopis I; Longo JPF; Báo SN
J Nanobiotechnology; 2020 Mar; 18(1):43. PubMed ID: 32164731
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and
Varshosaz J; Enteshari S; Hassanzadeh F; Hashemi-Beni B; Minaiyan M; Sadeghian-Rizi S
Anticancer Agents Med Chem; 2018; 18(14):2017-2031. PubMed ID: 30205803
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticles with Optimal Ratiometric Co-Delivery of Docetaxel with Gambogic Acid for Treatment of Multidrug-Resistant Breast Cancer.
Xu Y; Wang C; Ding Y; Wang Y; Liu K; Tian Y; Gao M; Li Z; Zhang J; Li L
J Biomed Nanotechnol; 2016 Sep; 12(9):1774-81. PubMed ID: 29345888
[TBL] [Abstract][Full Text] [Related]
16. Novel pH-triggered biocompatible polymeric micelles based on heparin-α-tocopherol conjugate for intracellular delivery of docetaxel in breast cancer.
Emami J; Kazemi M; Hasanzadeh F; Minaiyan M; Mirian M; Lavasanifar A
Pharm Dev Technol; 2020 Apr; 25(4):492-509. PubMed ID: 31903817
[TBL] [Abstract][Full Text] [Related]
17. Efficient in vitro and in vivo docetaxel delivery mediated by pH-sensitive LPHNPs for effective breast cancer therapy.
Jadon RS; Sharma G; Garg NK; Tandel N; Gajbhiye KR; Salve R; Gajbhiye V; Sharma U; Katare OP; Sharma M; Tyagi RK
Colloids Surf B Biointerfaces; 2021 Jul; 203():111760. PubMed ID: 33872827
[TBL] [Abstract][Full Text] [Related]
18. Enforced expression of hsa-miR-125a-3p in breast cancer cells potentiates docetaxel sensitivity via modulation of BRCA1 signaling.
Xu X; Lv YG; Yan CY; Yi J; Ling R
Biochem Biophys Res Commun; 2016 Oct; 479(4):893-900. PubMed ID: 27693788
[TBL] [Abstract][Full Text] [Related]
19. DKK4-knockdown enhances chemosensitivity of A549/DTX cells to docetaxel.
Yang X; Liu Y; Li W; Li A; Sun Q
Acta Biochim Biophys Sin (Shanghai); 2017 Oct; 49(10):899-906. PubMed ID: 28981599
[TBL] [Abstract][Full Text] [Related]
20. Impact of Docetaxel on blood-brain barrier function and formation of breast cancer brain metastases.
Bernatz S; Ilina EI; Devraj K; Harter PN; Mueller K; Kleber S; Braun Y; Penski C; Renner C; Halder R; Jennewein L; Solbach C; Thorsen F; Pestalozzi BC; Mischo A; Mittelbronn M
J Exp Clin Cancer Res; 2019 Oct; 38(1):434. PubMed ID: 31665089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]